Literature DB >> 21448203

Learning to live with patency of the ductus arteriosus in preterm infants.

W E Benitz1.   

Abstract

Treatment of persistent patency of the ductus arteriosus in preterm infants remains heterogeneous and controversial. Routine early treatment to induce ductal closure is not beneficial, but the potential criteria for, timing of, methods for and benefits of later ductal closure have not been determined. Management strategies for infants awaiting spontaneous closure or meeting criteria for treatment may be based on pathophysiological considerations but require evaluation in clinical trials. Better diagnostic tools allowing the identification of infants who might benefit from ductal closure, supplemented by data from clinical trials confirming realization of that potential, are urgently needed.

Entities:  

Mesh:

Year:  2011        PMID: 21448203     DOI: 10.1038/jp.2010.175

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  21 in total

1.  Serial N-terminal pro-brain natriuretic peptide measurement as a predictor of significant patent ductus arteriosus in preterm infants beyond the first week of life.

Authors:  Johannes Buca Letshwiti; Jan Sirc; Ruth O'Kelly; Jan Miletin
Journal:  Eur J Pediatr       Date:  2014-06-05       Impact factor: 3.183

2.  Short-term outcomes for preterm infants with surgical necrotizing enterocolitis.

Authors:  K Murthy; T D Yanowitz; R DiGeronimo; F D Dykes; I Zaniletti; J Sharma; K M Sullivan; J Mirpuri; J R Evans; R Wadhawan; A Piazza; I Adams-Chapman; J M Asselin; B L Short; M A Padula; D J Durand; E K Pallotto; K M Reber
Journal:  J Perinatol       Date:  2014-08-21       Impact factor: 2.521

Review 3.  Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all?

Authors:  Ronald I Clyman; James Couto; Gail M Murphy
Journal:  Semin Perinatol       Date:  2012-04       Impact factor: 3.300

4.  Potential Unintended Consequences of a Conservative Management Strategy for Patent Ductus Arteriosus.

Authors:  Justin J Elhoff; Myla Ebeling; Thomas C Hulsey; Andrew M Atz
Journal:  Congenit Heart Dis       Date:  2015-07-20       Impact factor: 2.007

5.  Natural evolution of the patent ductus arteriosus in the extremely premature newborn and respiratory outcomes.

Authors:  Gabriela de Carvalho Nunes; Punnanee Wutthigate; Jessica Simoneau; Marc Beltempo; Guilherme Mendes Sant'Anna; Gabriel Altit
Journal:  J Perinatol       Date:  2021-11-23       Impact factor: 2.521

6.  Comparative effectiveness and safety of indomethacin versus ibuprofen for the treatment of patent ductus arteriosus.

Authors:  Brian C Gulack; Matthew M Laughon; Reese H Clark; Meera N Sankar; Christoph P Hornik; P Brian Smith
Journal:  Early Hum Dev       Date:  2015-09-19       Impact factor: 2.079

Review 7.  Pharmacological Closure of Patent Ductus Arteriosus: Selecting the Agent and Route of Administration.

Authors:  Sindhu Sivanandan; Ramesh Agarwal
Journal:  Paediatr Drugs       Date:  2016-04       Impact factor: 3.022

8.  Trends and variation in management and outcomes of very low-birth-weight infants with patent ductus arteriosus.

Authors:  James I Hagadorn; Elizabeth A Brownell; Jennifer M Trzaski; Kendall R Johnson; Shabnam Lainwala; Brendan T Campbell; Katherine W Herbst
Journal:  Pediatr Res       Date:  2016-08-10       Impact factor: 3.756

9.  Neonatal Informatics: Transforming Neonatal Care Through Translational Bioinformatics.

Authors:  Jonathan P Palma; William E Benitz; Peter Tarczy-Hornoch; Atul J Butte; Christopher A Longhurst
Journal:  Neoreviews       Date:  2012-05-01

10.  Predictors of bronchopulmonary dysplasia or death in premature infants with a patent ductus arteriosus.

Authors:  Valerie Y Chock; Rajesh Punn; Anushri Oza; William E Benitz; Krisa P Van Meurs; Alice S Whittemore; Fariborz Behzadian; Norman H Silverman
Journal:  Pediatr Res       Date:  2013-12-30       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.